These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2443119)

  • 1. DNA-protein flow cytometric analysis in non-Hodgkin lymphoma.
    Del Bino G; Silvestrini R; Costa A; Mazzini G; Giordano P
    Basic Appl Histochem; 1987; 31(2):183-90. PubMed ID: 2443119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA content of T-cell lymphomas. A flow-cytometric analysis.
    Egerter DA; Said JW; Epling S; Lee S
    Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma.
    Wooldridge TN; Grierson HL; Weisenburger DD; Armitage JO; Sanger WG; Collins MM; Pierson JL; Pauza ME; Fordyce R; Purtilo DT
    Cancer Res; 1988 Nov; 48(22):6608-13. PubMed ID: 3052808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of low grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):263-9. PubMed ID: 7697327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of immunophenotypic and DNA values in non-Hodgkin's B-cell lymphomas classified according to the Kiel Classification and Working Formulation.
    Lackowska B; Niezabitowski A; Wasilewska A; Gruchała A; Ryś J; Szklarski W
    Pol J Pathol; 1994; 45(4):275-7. PubMed ID: 7697329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of high grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
    Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
    Pol J Pathol; 1994; 45(4):271-4. PubMed ID: 7697328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
    Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
    Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
    Joensuu H; Klemi PJ; Eerola E
    J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [DNA--ploidy in non hodgkin's lymphomas of low malignancy].
    Krygier-Stojałowska A; Urasiński I; Kuchnio M; Gapski Z
    Acta Haematol Pol; 1993; 24(2):153-60. PubMed ID: 8372615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic and prognostic value of flow cytometry study of the DNA content and cellular kinetics of paraffin embedded samples of lymphoma].
    Gómez Arbonés J; Macià Virgili J; Campo Guerri E; Parra López R; Gallart Blanco MA; Panadés Siurana MJ
    Sangre (Barc); 1994 Dec; 39(6):423-8. PubMed ID: 7855693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
    Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
    Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and clinical significance of cell kinetics in non-Hodgkin's lymphomas.
    Del Bino G; Silvestrini R; Costa A; Veneroni S; Giardini R
    Basic Appl Histochem; 1986; 30(2):197-202. PubMed ID: 3741316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
    Cowan RA; Harris M; Jones M; Crowther D
    Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
    Costa A; Mazzini G; Del Bino G; Silvestrini R
    Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of non-Hodgkin's lymphomas cell cycle data.
    Vucković J; Forenpoher G; Marusić M; UZarević B; Zemunik T
    Neoplasma; 1998; 45(5):332-5. PubMed ID: 9921923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
    Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
    Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.